Evidence map›Paper›PMID 35083333›Full record

ArticleBioMed research international2022

Immunological Risk Assessment of Xenogeneic Dural Patch by Comparing with Raw Material via GTKO Mice.

Yufeng Mu, Anliang Shao, Li Shi, Bin Du, Yongjie Zhang, Jie Luo, Liming Xu, Shuxin Qu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yufeng MuSchool of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.ORCID https://orcid.org/0000-0001-6059-5681
Anliang ShaoInstitute for Medical Device Control, National Institutes for Food and Drug Control, Beijing 102629, China.
Li ShiShaanxi Bioregenerative Medicine Co., Ltd., Xi'an 710100, China.
Bin DuShaanxi Bioregenerative Medicine Co., Ltd., Xi'an 710100, China.
Yongjie ZhangShaanxi Bioregenerative Medicine Co., Ltd., Xi'an 710100, China.
Jie LuoShaanxi Bioregenerative Medicine Co., Ltd., Xi'an 710100, China.
Liming XuSchool of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.ORCID https://orcid.org/0000-0002-3577-0959
Shuxin QuSchool of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.ORCID https://orcid.org/0000-0001-9049-9332
Microbiology Institute of Shaanxi · CNNational Institutes for Food and Drug Control · CNSouthwest Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study,

methodsThe xenogeneic dural patch (T2) was prepared from bovine pericardium (T1, raw material) through decellularization and carboxymethyl chitosan (CMCS) coating. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) were used to characterize the collagen fibers and surface microstructural changes in the T1 and T2 samples. The remnant

resultsTEM and Sirius red staining showed that the collagen fibers in the dural patch were closely arranged, and SEM showed that a loose three-dimensional structure was successfully constructed on the surface of the dural patch after CMCS coating. The remnant DNA in T2 was 24.64 ± 8.73 ng/mg (dry weight), and clearance of

conclusionsThe results demonstrated that the xenogeneic dural patch has a lower and acceptable immunological risk compared to the raw material and control, respectively. On the other hand, it was suggested that GTKO mice are useful experimental model for immunological risk assessment of animal tissue-derived biomaterials.

Indexed as

CollagenImmunoglobulin GAnimalsCattleEpitopesImmunoglobulin MMiceMice, KnockoutRisk AssessmentTransplantation, HeterologousCollagenEpitopesImmunoglobulin GImmunoglobulin M

Identifiers

PMID35083333
PMCPMC8786519
OpenAlexW4205917138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.